DeepMed Research

PT Bio Farma

🇮🇩Indonesia

Country: 🇮🇩Indonesia

Ownership: Private

Established: 1890-01-01

Employees: 501

Market Cap: -

Website: http://www.biofarma.co.id

Clinical Trials

Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV

Not yet recruiting

Conditions: Antibody Typhoid Vaccine

First Posted Date: 2025-04-10

Last Posted Date: 2025-04-10

Lead Sponsor: PT Bio Farma

Target Recruit Count: 624

Registration Number: NCT06921460

Locations: 🇮🇩
Department of Child Health Dr. Soetomo Hospital/School of Medicine, Airlangga University, Surabaya, East Java, Jakarta, DKI Jakarta, Indonesia

Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants

Phase 1

Not yet recruiting

Conditions: Vaccine Adverse Reaction
Vaccine Reaction

Interventions: Biological: DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula A
Biological: DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula B
Biological: Registered DTwP-Hepatitis B-Hib Vaccine and IPV (Sinovac)®

First Posted Date: 2024-11-15

Last Posted Date: 2024-11-15

Lead Sponsor: PT Bio Farma

Target Recruit Count: 465

Registration Number: NCT06690515

Locations: 🇮🇩
Garuda Primary Health Centre, Bandung, West Java, Indonesia
🇮🇩
Ibrahim Adjie Priamry Health Centre, Bandung, West Java, Indonesia
🇮🇩
Puter Primary Health Centre, Bandung, West Java, Indonesia

Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination

Completed

Conditions: COVID-19

First Posted Date: 2024-11-15

Last Posted Date: 2024-11-15

Lead Sponsor: PT Bio Farma

Target Recruit Count: 1208

Registration Number: NCT06690502

Locations: 🇮🇩
Gambir Public Health Center, Jakarta, Center Jakarta, Indonesia
🇮🇩
Kemayoran Public Health Center, Jakarta, Center Jakarta, Indonesia
🇮🇩
Menteng Public Health Center, Jakarta, Center Jakarta, Indonesia

and more 25 locations

Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial

Phase 4

Recruiting

Conditions: Safety Issues
Effect of Drug

Interventions: Drug: Enoxaparin sodium injection

First Posted Date: 2023-11-02

Last Posted Date: 2023-11-02

Lead Sponsor: PT Bio Farma

Target Recruit Count: 220

Registration Number: NCT06114641

Locations: 🇮🇩
RSUP Dr.Sardjito, Yogyakarta, Yogyakarta, D.I.Yogyakarta, Indonesia
🇮🇩
RSUP Prof. Dr. I.G.N.G Ngoerah, Bali, Bali, Indonesia
🇮🇩
RS Jantung dan Pembuluh Darah Harapan Kita, Jakarta, Jakarta, DKI Jakarta, Indonesia

Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)

Not Applicable

Completed

Conditions: Human Papilloma Virus Infection

Interventions: Diagnostic Test: HPV Diagnostic Kit (Bio Farma)

First Posted Date: 2023-11-01

Last Posted Date: 2023-11-01

Lead Sponsor: PT Bio Farma

Target Recruit Count: 900

Registration Number: NCT06111911

Locations: 🇮🇩
Cipto Mangunkusumo Hospital, Jakarta, DKI Jakarta, Indonesia

Post Marketing Surveillance of Diphtheria Antitoxin (DAT)

Phase 4

Completed

Conditions: Safety Issues

Interventions: Biological: Diphtheria Antitoxin

First Posted Date: 2023-09-26

Last Posted Date: 2023-11-18

Lead Sponsor: PT Bio Farma

Target Recruit Count: 68

Registration Number: NCT06053853

Locations: 🇮🇩
RSUD Dr. Soetomo, Surabaya, East Java, Indonesia

Post Authorization Safety Study Moderna COVID-19 Primary Vaccine

Completed

Conditions: COVID-19

Interventions: Biological: Moderna COVID-19 Vaccine

First Posted Date: 2023-08-23

Last Posted Date: 2023-11-18

Lead Sponsor: PT Bio Farma

Target Recruit Count: 1284

Registration Number: NCT06006858

Locations: 🇮🇩
Cengkareng Public Health Center, Jakarta, Indonesia
🇮🇩
Kebon Jeruk Public Health Center, Jakarta, Indonesia
🇮🇩
Tebet Public Health Center, Jakarta, Indonesia

and more 15 locations

Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

Phase 2

Not yet recruiting

Conditions: COVID-19

First Posted Date: 2023-07-06

Last Posted Date: 2023-07-07

Lead Sponsor: PT Bio Farma

Target Recruit Count: 150

Registration Number: NCT05933278

Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age

Phase 2

Active, not recruiting

Conditions: COVID-19

Interventions: Biological: SARS-CoV-2 subunit protein recombinant vaccine

First Posted Date: 2023-02-14

Last Posted Date: 2023-08-24

Lead Sponsor: PT Bio Farma

Target Recruit Count: 150

Registration Number: NCT05727215

Locations: 🇮🇩
Faculty of Medicine Universitas Padjadjaran, Bandung, Jawa Barat, Indonesia

Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung

Not Applicable

Recruiting

Conditions: Diabetes Mellitus, Type 2

Interventions: Device: Manual Records
Device: Medwell Preventive Care Application

First Posted Date: 2022-12-20

Last Posted Date: 2023-04-19

Lead Sponsor: PT Bio Farma

Target Recruit Count: 160

Registration Number: NCT05657769

Locations: 🇮🇩
Immanuel Hospital, Bandung, West Java, Indonesia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy